Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
West Pharmaceutical ServicesMEX:WST 94 3-Year Dividend Growth Rate is 5.20% as of Jun. 2026, which is 26% below its 10-year median of 7.00. GuruFocus rates MEX:WST with a GF Score™ of 94/100 and a GF Value™ of MXN5,282.62. The stock has 9 warning signs investors should review. Among 223 Medical Devices & Instruments companies, West Pharmaceutical Services ranks worse than 52.47% on this metric.
The historical rank and industry rank for West Pharmaceutical Services's 3-Year Dividend Growth Rate or its related term are showing as below:
MEX:WST'
s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 1 Med: 7 Max: 13.7
Current: 5.2
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of West Pharmaceutical Services was 13.70% per year. The lowest was 1.00% per year. And the median was 7.00% per year.
MEX:WST's 3-Year Dividend Growth Rate is ranked worse than 52.47% of 223
companies
in the Medical Devices & Instruments industry
Industry Median: 5.6
vs MEX:WST: 5.20
During the past 12 months, West Pharmaceutical Services's average Dividends Per Share Growth Rate was 4.80% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 5.20% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 5.50% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 6.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
During the past 13 years, the highest Dividend Payout Ratio of West Pharmaceutical Services was 0.23. The lowest was 0.08. And the median was 0.13.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
West Pharmaceutical Services Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
USD 0.220000
2026-07-29
2026-07-29
2026-08-05
Cash Dividend
quarterly
USD:MXN 17.455700
USD 0.220000
2026-04-29
2026-04-29
2026-05-06
Cash Dividend
quarterly
USD:MXN 17.454400
USD 0.220000
2026-01-28
2026-01-28
2026-02-04
Cash Dividend
quarterly
USD:MXN 17.644600
USD 0.220000
2025-11-12
2025-11-12
2025-11-19
Cash Dividend
quarterly
USD:MXN 18.419300
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
West Pharmaceutical Services's Dividend Yield (%) for Today is calculated as
Current Share Price is MXN5112.51.
West Pharmaceutical Services's Dividends per Share for the trailing twelve months (TTM) ended in Today is MXN15.61428.
During the past 13 years, the highest Dividend Yield of West Pharmaceutical Services was 0.67%. The lowest was 0.00%. And the median was 0.30%.
Warning Sign:
West Pharmaceutical Services Inc stock Dividend Yield % is close to 2-year low.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
West Pharmaceutical Services 3-Year Dividend Growth Rate Related Terms>
MEX:WST vs MDLN, SOLV, COO: 3-Year Dividend Growth Rate Comparison
For the Medical Instruments & Supplies subindustry, West Pharmaceutical Services's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
West Pharmaceutical Services 3-Year Dividend Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, West Pharmaceutical Services's 3-Year Dividend Growth Rate distribution charts can be found below:
* The bar in red indicates where West Pharmaceutical Services's 3-Year Dividend Growth Rate falls into.
West Pharmaceutical Services 3-Year Dividend Growth Rate Calculation
This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 3-Year Dividend Growth Rate of 5.20% mean?
West Pharmaceutical Services (MEX:WST) has a 3-Year Dividend Growth Rate of 5.20% as of Jun. 2026. 3-Year Dividend Growth Rate is the company's three-year average growth of dividend payout. View historical data on West Pharmaceutical Services and its competitors. This is 26% below median its historical median of 7.00. Over the past decade, West Pharmaceutical Services' 3-Year Dividend Growth Rate has ranged from 1.00 to 13.70. According to the industry distribution chart, West Pharmaceutical Services ranks #117 out of 223 companies in the Medical Devices & Instruments industry, placing it in the top 52.5%.
Is West Pharmaceutical Services' 3-Year Dividend Growth Rate too high?
West Pharmaceutical Services' current 3-Year Dividend Growth Rate of 5.20% is 26% below median its 10-year median of 7.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 13.70. The Medical Devices & Instruments industry median 3-Year Dividend Growth Rate is 5.60. West Pharmaceutical Services' value of 5.20% is 7.1% below this industry median. Based on the distribution chart, West Pharmaceutical Services ranks #117 out of 223 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, West Pharmaceutical Services has a GF Score™ of 94/100, reflecting its overall financial health beyond just this single metric.
How does West Pharmaceutical Services' 3-Year Dividend Growth Rate compare to MDLN and SOLV?
According to the Medical Devices & Instruments industry distribution chart, West Pharmaceutical Services ranks #117 out of 223 companies for 3-Year Dividend Growth Rate. This places West Pharmaceutical Services in the lower half of its industry. The industry median 3-Year Dividend Growth Rate is 5.60. West Pharmaceutical Services' value of 5.20% is 7.1% below this benchmark. Historically, West Pharmaceutical Services' own 3-Year Dividend Growth Rate has ranged from 1.00 to 13.70 over the past decade. While the company's 10-year median is 7.00 vs. the industry median of 5.60, West Pharmaceutical Services has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Dividend Growth Rate for a Medical Devices & Instruments company?
The median 3-Year Dividend Growth Rate among Medical Devices & Instruments companies is 5.60, based on 223 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Dividend Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Dividend Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. West Pharmaceutical Services's current 3-Year Dividend Growth Rate of 5.20% is 7.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Dividend Growth Rate mean?
A high 3-Year Dividend Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Dividend Growth Rate is the company's three-year average growth of dividend payout. View historical data on West Pharmaceutical Services and its competitors. For the Medical Devices & Instruments industry, the median 3-Year Dividend Growth Rate is 5.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. West Pharmaceutical Services's current 3-Year Dividend Growth Rate is 5.20%, which is 26% below median its own 10-year median of 7.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is West Pharmaceutical Services stock overvalued right now?
West Pharmaceutical Services (MEX:WST) has a current 3-Year Dividend Growth Rate of 5.20%. The stock's GF Value™ is MXN5,282.62, compared to a current price of MXN5,112.51 — trading 3.2% below its estimated fair value. The current 3-Year Dividend Growth Rate is 5.20%, which is 26% below median its 10-year median of 7.00 and 7.1% below the Medical Devices & Instruments industry median of 5.60. West Pharmaceutical Services' overall GF Score™ is 94/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Dividend Growth Rate calculated?
3-Year Dividend Growth Rate is calculated from a company's financial statements. For West Pharmaceutical Services (MEX:WST), the current 3-Year Dividend Growth Rate is 5.20% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is West Pharmaceutical Services (MEX:WST) Overvalued in 2026?
Based on GuruFocus' analysis, West Pharmaceutical Services stock appears to be undervalued.
The current stock price of MXN5,112.51 is trading 3.2% below its estimated GF Value™ of MXN5,282.62.
Key valuation signals for MEX:WST:
3-Year Dividend Growth Rate: 5.20% (26% below median its 10-year median of 7.00)
GF Value™: MXN5,282.62 vs. price of MXN5,112.51 (3.2% below fair value)
Industry Position: 7.1% below the Medical Devices & Instruments median (#117 of 223)
No single metric tells the full story. See the MEX:WST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
West Pharmaceutical Services Inc. is a Pennsylvania-based supplier to the pharmaceutical, biotechnology, and generic drug industries. The company provides elastomer-based packaging components such as stoppers, seals, and plungers, along with non-glass containment solutions and self-injection devices including auto-injectors and pen injectors. Its products support injectable drugs, including large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. West reports in two segments: proprietary products, which account for the majority of revenue and include its high-value packaging and delivery systems, and contract-manufactured products, which involve manufacturing services for other companies. Customers include pharmaceutical and biotechnology firms worldwide. The company generates a substantial share of revenue from international markets, with the remainder from the United States. Its revenue model centers on selling consumable packaging components and delivery devices tied to ongoing drug production, supplemented by contract manufacturing services.
94GF Score
Get the complete analysis for MEX:WST
3-Year Dividend Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:WST has been successfully added to your 
